Canandaigua National Corp Danaher Corp Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Danaher Corp stock. As of the latest transaction made, Canandaigua National Corp holds 12,940 shares of DHR stock, worth $3.56 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

12,940

Previous 13,460 3.86%

Holding current value

$3.56 Million

Previous $3.48 Million 1.21%

% of portfolio

0.58%

Previous 0.62%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$241.42 - $282.29 $125,538 - $146,790	-520 Reduced 3.86%	12,940 $3.44 Million
Q3 2022 Oct 05, 2022	SELL	$247.06 - $1507.4 $147,000 - $896,903	-595 Reduced 4.23%	13,460 $3.48 Million
Q2 2022 Jul 05, 2022	SELL	$237.11 - $299.66 $49,793 - $62,928	-210 Reduced 1.47%	14,055 $3.56 Million
Q1 2022 May 09, 2022	SELL	$257.27 - $315.76 $33,187 - $40,733	-129 Reduced 0.9%	14,265 $4.18 Million
Q4 2021 Jan 04, 2022	SELL	$292.08 - $329.01 $361,595 - $407,314	-1,238 Reduced 7.92%	14,394 $4.74 Million
Q3 2021 Oct 04, 2021	SELL	$272.21 - $332.43 $208,512 - $254,641	-766 Reduced 4.67%	15,632 $4.76 Million
Q2 2021 Jul 06, 2021	SELL	$225.08 - $271.69 $199,195 - $240,445	-885 Reduced 5.12%	16,398 $4.4 Million
Q1 2021 Apr 05, 2021	SELL	$212.38 - $245.9 $10,194 - $11,803	-48 Reduced 0.28%	17,283 $3.89 Million
Q4 2020 Feb 11, 2021	SELL	$212.5 - $245.46 $311,312 - $359,598	-1,465 Reduced 7.79%	17,331 $3.85 Million
Q3 2020 Oct 19, 2020	BUY	$177.16 - $215.33 $18,956 - $23,040	107 Added 0.57%	18,796 $4.05 Million
Q2 2020 Jul 07, 2020	BUY	$128.7 - $176.83 $2.41 Million - $3.3 Million	18,689 New	18,689 $3.31 Million

Others Institutions Holding DHR

# of Institutions

2,389

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $201B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Danaher Corp Transaction History